During the 12-month study , 47 % of the sample reduced their smoking , 80 % quit for 24 hr , and 11 % , 13 % , and 17 % confirmed 7-day point prevalence abstinence at 3 - , 6 - , and 12-month follow-up , respectively , with no differences by treatment condition ( ps > .400 ) .